Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) Is Not Attributed to MSH3 Loss in Stage I-III Colon cancer: An Automated, Digitalized Assessment by Immunohistochemistry of Whole Slides and Hot Spots
INTRODUCTION: EMAST is a poorly understood form of microsatellite instability (MSI) in colorectal cancer (CRC) for which loss of MSH3 has been proposed as the underlying mechanism, based on experimental studies. We aimed to evaluate whether MSH3 loss is associated with EMAST in CRC. METHODS: A conse...
Main Authors: | Martin M Watson, Dordi Lea, Hanne R. Hagland, Kjetil Søreide |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523319303146 |
Similar Items
-
Elevated Microsatellite Alterations at Selected Tetranucleotide repeats (EMAST) testing in colorectal cancer using the costeffective qiaxcel advanced platform
by: S. Mohammadpour, et al.
Published: (2019-04-01) -
Microsatellite instability (MSI, EMAST) in the pathogenesis of follicular lymphoma
by: K. A. Sychevskaya, et al.
Published: (2021-06-01) -
MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells.
by: Christoph Campregher, et al.
Published: (2012-01-01) -
Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma
by: Choi Ho, et al.
Published: (2008-12-01) -
EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
by: Sabine Venderbosch, et al.
Published: (2015-01-01)